✦ LIBER ✦

Adverse events reported by postmenopausal women in controlled trials with raloxifene

✍ Scribed by Graham C Davies; William J Huster; Yili Lu; Leo Plouffe Jr; Mark Lakshmanan

Book ID: 117193201
Publisher: Lippincott Williams and Wilkins
Year: 1999
Tongue: English
Weight: 269 KB
Volume: 93
Category: Article
ISSN: 0029-7844
DOI: 10.1016/s0029-7844(98)00476-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Raloxifene on Cardiovascular A

Effect of Raloxifene on Cardiovascular Adverse Events in Postmenopausal Women With Osteoporosis

✍ Kristine Ensrud; Andrea Riccardo Genazzani; Mary Jane Geiger; Michelle McNabb; S 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Characterization of hot flashes reported

Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials

✍ Fredric J Cohen; Yili Lu 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Raloxifene and cardiovascular events in

Raloxifene and cardiovascular events in osteoporotic postmenopausal women. Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial

✍ E. Barrett-Connor; D. Grady; A. Sashegyi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Raloxifene and estrogen effects on quali

Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial

✍ Ronald Strickler; Dale W Stovall; Diane Merritt; Wei Shen; Mayme Wong; Sheryl L 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 210 KB

Effect of raloxifene combined with monof

Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial

✍ JeanYves Reginster; Dieter Felsenberg; Imre Pavo; Jan Stepan; Juraj Payer; Heinr 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 254 KB

Bone Histomorphometric and Biochemical M

Bone Histomorphometric and Biochemical Marker Results of a 2-Year Placebo-Controlled Trial of Raloxifene in Postmenopausal Women

✍ Susan M. Ott; Anna Oleksik; Yili Lu; Kristine Harper; Paul Lips 📂 Article 📅 2002 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 107 KB